Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Logusgyn
- Development stage
- Unknown
- Lead developer
- Logus Pharma
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Topical, Vaginal
01
Overview
Logusgyn is a gynecological medical device line containing a combination of tindalised (heat-inactivated) probiotic cultures, including Lactobacillus casei, Lactobacillus acidophilus, Lactobacillus plantarum, and Streptococcus thermophilus. It is available in formulations such as vaginal ovules and lavage (douches) specifically designed for the treatment of non-specific vulvovaginitis and bacterial vaginosis. The device functions by restoring and maintaining the physiological vaginal microbiota and pH balance. By utilizing tindalised bacteria, Logusgyn provides the benefits of bacterial cell wall components (paraprobiotics) that can modulate local immune responses and inhibit the adhesion of pathogenic microorganisms to the vaginal mucosa, offering a therapeutic alternative to live probiotics.
- Brand names
- LogusgynCandidepLogusgyn OvulesLogusgyn LavenderLogusgyn Lavanda
- Other names
- Logusgyn/Candidep OvulesLogusgyn/Candidep Lavender
Beyond the preview
Go deeper on Logusgyn.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Logusgyn.